Bär & Karrer: KKR to invest in Precipart Group
Kohlberg Kravis Roberts (KKR) makes a significant investment into the Precipart Group, a renowned contract manufacturer of high-precision components to the medical, aerospace and industrial markets. KKR plans to support the company in its continued growth organically and through M&A.
Precipart, founded in 1950 by the Laubscher family with roots in Swiss engineering and manufacturing, is a leading contract development and manufacturing organization of highly engineered precision components and assemblies.
KKR is investing in Precipart through its Health Care Strategic Growth Fund, a fund dedicated to investing in high-growth healthcare-related companies to which they can be a unique strategic partner in helping reach scale.
Bär & Karrer acted as Swiss legal advisor to Kohlberg Kravis Roberts & Co. in this transaction. The team is led by Mariel Hoch (pictured) and includes Fabienne Perlini-Frehner, Sophie Aiko Müller and Joshua Baisch (all corporate/M&A), Micha Schilling (finance), Markus Wang and Christine Schweikard (both IP/IT), Laura Widmer and Luljeta Morina (both employment), Rocco Rigozzi (real estate), Peter Hsu, Tiffany Ender and Reto Kuoni (all insurance), Ruth Bloch-Riemer and Marco Weiss (both social security), Susanne Schreiber, Martin Leu and Fabian Capt (all tax), Thomas Stoltz, Özden Omürcan and Mia Baric (all notarial services).
